| scholarly article | Q13442814 |
| P2093 | author name string | Heng Li | |
| Hua Xu | |||
| Wei Xiao | |||
| Bin Lang | |||
| Gan Yu | |||
| Weimin Yao | |||
| P2860 | cites work | The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44 | Q24617130 |
| Amplification of LAPTM4B and YWHAZ contributes to chemotherapy resistance and recurrence of breast cancer | Q24644185 | ||
| Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells | Q24657020 | ||
| MiR-34a targeting of Notch ligand delta-like 1 impairs CD15+/CD133+ tumor-propagating cells and supports neural differentiation in medulloblastoma | Q27320938 | ||
| The functions of animal microRNAs | Q27860621 | ||
| Origins and Mechanisms of miRNAs and siRNAs | Q27860822 | ||
| MicroRNAs: genomics, biogenesis, mechanism, and function | Q27861070 | ||
| Micro-RNA profiling in kidney and bladder cancers | Q28247306 | ||
| Causes and consequences of microRNA dysregulation in cancer | Q28258994 | ||
| Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34 | Q28285980 | ||
| Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer | Q28291502 | ||
| Cisplatin-induced epigenetic activation of miR-34a sensitizes bladder cancer cells to chemotherapy | Q33615709 | ||
| Activation of β-catenin and Akt pathways by Twist are critical for the maintenance of EMT associated cancer stem cell-like characters | Q33809987 | ||
| Non-invasive detection of bladder cancer by identification of abnormal CD44 proteins in exfoliated cancer cells in urine | Q33837593 | ||
| p53 regulates glucose metabolism by miR-34a. | Q46913843 | ||
| Immunohistochemical expression of CD44s in renal cell carcinoma lacks independent prognostic significance. | Q51326636 | ||
| Prognostic significance of CA 125, CD44, and epithelial membrane antigen in renal cell carcinoma | Q57904997 | ||
| Translating MicroRNA discovery into clinical biomarkers in cancer | Q80249634 | ||
| A sequence variant at 4p16.3 confers susceptibility to urinary bladder cancer | Q34071175 | ||
| MicroRNA-34a suppresses invasion through downregulation of Notch1 and Jagged1 in cervical carcinoma and choriocarcinoma cells. | Q34107306 | ||
| OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma. | Q34130311 | ||
| Axillary node metastasis from differentiated thyroid carcinoma with Hürthle and signet ring cell differentiation. A case of disseminated thyroid cancer with peculiar histologic findings. | Q34150517 | ||
| miR-143, miR-222, and miR-452 are useful as tumor stratification and noninvasive diagnostic biomarkers for bladder cancer | Q34262050 | ||
| Li-Fraumeni syndrome with simultaneous osteosarcoma and liver cancer: increased expression of a CD44 variant isoform after chemotherapy | Q34432525 | ||
| miR-19a acts as an oncogenic microRNA and is up-regulated in bladder cancer | Q34544501 | ||
| CD44 splice isoform switching in human and mouse epithelium is essential for epithelial-mesenchymal transition and breast cancer progression | Q34627193 | ||
| MicroRNA-320c inhibits tumorous behaviors of bladder cancer by targeting Cyclin-dependent kinase 6 | Q35605883 | ||
| MicroRNA-34a suppresses malignant transformation by targeting c-Myc transcriptional complexes in human renal cell carcinoma | Q35730683 | ||
| Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer | Q35855955 | ||
| Chromosome 4p16.3 variant modify bladder cancer risk in a Chinese population | Q35857520 | ||
| Sequence variant on 8q24 confers susceptibility to urinary bladder cancer | Q35964294 | ||
| CD44+/CD24- phenotype contributes to malignant relapse following surgical resection and chemotherapy in patients with invasive ductal carcinoma | Q36202984 | ||
| CD44 is associated with tumor recurrence and is an independent poor prognostic factor for patients with localized clear cell renal cell carcinoma after nephrectomy | Q36224896 | ||
| Plasma specific miRNAs as predictive biomarkers for diagnosis and prognosis of glioma | Q36560956 | ||
| Epidemiology of urinary bladder cancer: from tumor development to patient's death | Q36832297 | ||
| A microRNA DNA methylation signature for human cancer metastasis | Q36861111 | ||
| Dicer-dependent endothelial microRNAs are necessary for postnatal angiogenesis | Q36893701 | ||
| MicroRNAs as regulators of epithelial-mesenchymal transition. | Q37300965 | ||
| Recurrence and progression of disease in non-muscle-invasive bladder cancer: from epidemiology to treatment strategy | Q37540810 | ||
| Increased CD44s and decreased CD44v6 RNA expression are associated with better survival in myxofibrosarcoma patients: a pilot study | Q37616756 | ||
| MicroRNAs in colorectal cancer: translation of molecular biology into clinical application | Q37632608 | ||
| MicroRNA in prostate, bladder, and kidney cancer: a systematic review. | Q37836137 | ||
| miRNA-34a suppresses cell proliferation and metastasis by targeting CD44 in human renal carcinoma cells | Q38991056 | ||
| Inversed relationship between CD44 variant and c-Myc due to oxidative stress-induced canonical Wnt activation. | Q39044097 | ||
| EpCAM expression in the prostate cancer makes the difference in the response to growth factors | Q39048151 | ||
| MiR-34a targets GAS1 to promote cell proliferation and inhibit apoptosis in papillary thyroid carcinoma via PI3K/Akt/Bad pathway | Q39063949 | ||
| Delta-tocotrienol suppresses Notch-1 pathway by upregulating miR-34a in nonsmall cell lung cancer cells | Q39375782 | ||
| miR-34a predicts survival of Ewing's sarcoma patients and directly influences cell chemo-sensitivity and malignancy | Q39465507 | ||
| MiR-34a chemosensitizes bladder cancer cells to cisplatin treatment regardless of p53-Rb pathway status | Q39518813 | ||
| Circulating miR-34a levels are reduced in colorectal cancer | Q39610241 | ||
| Associations between circulating microRNAs (miR-21, miR-34a, miR-122 and miR-451) and non-alcoholic fatty liver. | Q44615667 | ||
| P921 | main subject | microRNA | Q310899 |
| P304 | page(s) | 779 | |
| P577 | publication date | 2014-12-31 | |
| P1433 | published in | Journal of Experimental & Clinical Cancer Research | Q13739415 |
| P1476 | title | MicroRNA-34a functions as an anti-metastatic microRNA and suppresses angiogenesis in bladder cancer by directly targeting CD44 | |
| P478 | volume | 33 |
| Q64263672 | Anti-cancer Effects of a Chemically Modified miR-143 on Bladder Cancer by Either Systemic or Intravesical Treatment |
| Q58697956 | CD44/CD44v6 a Reliable Companion in Cancer-Initiating Cell Maintenance and Tumor Progression |
| Q63561064 | CD44s is a crucial ATG7 downstream regulator for stem-like property, invasion, and lung metastasis of human bladder cancer (BC) cells |
| Q36529359 | Characteristics of Patients With Transitional Cell Carcinoma of the Urinary Bladder in Kermanshah Province, Iran |
| Q37210703 | Combined expression of miR-34a and Smac mediated by oncolytic vaccinia virus synergistically promote anti-tumor effects in Multiple Myeloma |
| Q39331536 | Current Concepts of Epigenetics in Testicular Cancer |
| Q33689126 | Dysregulation of miRNAs in bladder cancer: altered expression with aberrant biogenesis procedure |
| Q92072853 | Epigenetics of Bladder Cancer: Where Biomarkers and Therapeutic Targets Meet |
| Q35825993 | Hypoxia-inducible MiR-182 promotes angiogenesis by targeting RASA1 in hepatocellular carcinoma |
| Q26770381 | Interplay Between Metabolism and Oncogenic Process: Role of microRNAs |
| Q35869716 | Low expression of microRNA-204 (miR-204) is associated with poor clinical outcome of acute myeloid leukemia (AML) patients. |
| Q90079974 | MicroRNA Networks Modulate Oxidative Stress in Cancer |
| Q37699408 | MicroRNA-34a expression levels in serum and intratumoral tissue can predict bone metastasis in patients with hepatocellular carcinoma |
| Q90441365 | MicroRNA-34a suppresses breast cancer cell proliferation and invasion by targeting Notch1 |
| Q50221158 | MicroRNA-34a suppresses invasion and metastatic in esophageal squamous cell carcinoma by regulating CD44. |
| Q43184280 | MicroRNA-34a: A Key Regulator in the Hallmarks of Renal Cell Carcinoma |
| Q44463289 | MicroRNA-34a: A Versatile Regulator of Myriads of Targets in Different Cancers. |
| Q47703386 | MicroRNAs in cancer metastasis and angiogenesis |
| Q64093654 | Obatoclax, a BH3 Mimetic, Enhances Cisplatin-Induced Apoptosis and Decreases the Clonogenicity of Muscle Invasive Bladder Cancer Cells via Mechanisms That Involve the Inhibition of Pro-Survival Molecules as Well as Cell Cycle Regulators |
| Q35344075 | Signaling by exosomal microRNAs in cancer. |
| Q26741223 | The Significance of Epithelial-to-Mesenchymal Transition for Circulating Tumor Cells |
| Q26771509 | The role of CD44 in epithelial-mesenchymal transition and cancer development |
| Q26744149 | The role of microRNAs in bladder cancer |
| Q39432577 | Understanding the Role of Non-Coding RNAs in Bladder Cancer: From Dark Matter to Valuable Therapeutic Targets. |
| Q55126311 | Understanding the biology of urothelial cancer metastasis. |
| Q90381696 | c-Myc Acts as a Competing Endogenous RNA to Sponge miR-34a, in the Upregulation of CD44, in Urothelial Carcinoma |
| Q41646109 | miR-107 promotes hepatocellular carcinoma cell proliferation by targeting Axin2. |
| Q90046505 | miRNA-34a inhibits cell adhesion by targeting CD44 in human renal epithelial cells: implications for renal stone disease |
| Q38764391 | miRNA-34a promotes proliferation of human pulmonary artery smooth muscle cells by targeting PDGFRA. |
| Q89883646 | miRNAs: A Promising Target in the Chemoresistance of Bladder Cancer |
| Q39285150 | miRNAs: micro-managers of anticancer combination therapies. |
Search more.